Sort
10,766 grants matching “checkpoint inhibitor”
Defining the role of aberrant signal pathway activation in melanoma on the immune microenvironment
$51,036Amanda Truong · University Of Utah · F30 · FY2021 · CA
Characterizing the DPP8/9 Pyroptotic Checkpoint with Chemoproteomic Protease Substrate Profiling
$51,036Andrew Griswold · Weill Medical Coll Of Cornell Univ · F30 · FY2021 · CA
Identifying the Role of Tumor Cell Intrinsic DNMT1 in Anti-Tumor Immunity in Pancreatic Ductal Adenocarcinoma
$51,036Erin Elizabeth Hollander · University Of Pennsylvania · F30 · FY2021 · CA
Function of IRF8 in T cell activation and immune tolerance
$51,036John David Klement · Augusta University · F30 · FY2021 · CA
Exploring the Innate Sensors Underlying Cancer Immunosurveillance
$51,036Daniel J Kim · Yale University · F30 · FY2021 · CA
Elucidating the protective role of stromal fibrosis to radiation-induced tumor immunity
$51,036Varintra Edlyn Lander · Washington University · F30 · FY2021 · CA
Validation of WEE1 kinase as a clinical target in KRAS-mutant pancreatic cancer
$51,036John Nathaniel Diehl · Univ Of North Carolina Chapel Hill · F30 · FY2021 · CA
Uncovering interactions of the gut microbiome with the immune system in the context of immune checkpoint inhibitors
$51,036Jennifer Chung · University Of Connecticut Sch Of Med/Dnt · F30 · FY2021 · CA
Impact of local and systemic cellular senescence toward Triple Negative Breast Cancer growth and drug therapy
$51,036Irfan Khan · Georgetown University · F30 · FY2021 · CA
Mechanistic Dissection and Therapeutic Targeting of B7x in Cancer
$51,036Christopher D Nishimura · Albert Einstein College Of Medicine · F30 · FY2021 · CA
B7x in Cancer: Mechanisms and Therapies
$51,036Peter John · Albert Einstein College Of Medicine · F30 · FY2021 · CA
GU Malignancies Research Program
$51,030Nima Sharifi · Case Western Reserve University · P30 · FY2020 · CA
Developmental Therapeutics Research Program
$51,030John James Letterio · Case Western Reserve University · P30 · FY2020 · CA
Chk1 and Chk2 in Human Cancer Cells
$50,860Deborah F Wilsker · Johns Hopkins University · F32 · FY2009 · CA
Developmental Therapeutics Research Program
$50,794John James Letterio · Case Western Reserve University · P30 · FY2018 · CA
Function of PD-1 Signaling on the Activity of B cells in the Tumor Microenvironment in Breast Cancer
$50,717Xiaolu Pan · Univ Of North Carolina Chapel Hill · F31 · FY2025 · CA
Title: Pre-clinical Evaluation of a Novel Immune Modulator, Alpha-TEA in Combination with Immune Checkpoint Blockade
$50,521Emmanuel T Akporiaye · Veana Therapeutics, Llc · R43 · FY2019 · CA
Function of IRF8 in T cell activation and immune tolerance
$50,520John David Klement · Augusta University · F30 · FY2020 · CA
Augmenting Pancreatic Cancer Immunotherapy via TGFβ Pathway Inhibition
$50,520Daniel R Principe · University Of Illinois At Chicago · F30 · FY2020 · CA
B7x in Cancer: Mechanisms and Therapies
$50,520Peter John · Albert Einstein College Of Medicine · F30 · FY2020 · CA
Pglyrp3 cooperates with Snail1 to mediate anti-tumor immune response in breast cancer
$50,520Mathew Sebastian · University Of Florida · F30 · FY2020 · CA
Modeling the Immune Response to Melanoma Brain Metastases in Mice
$50,520Irina Krykbaeva · Yale University · F30 · FY2020 · CA
Defining the role of aberrant signal pathway activation in melanoma on the immune microenvironment
$50,520Amanda Truong · University Of Utah · F30 · FY2020 · CA
CV301 and Anti-PD-1 Therapy in Non-Small Cell Lung Cancer
$50,506Arun Rajan · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Research Program
$50,472Olga Anczukow-Camarda · Jackson Laboratory · P30 · FY2024 · CA